Related Experiment Video
Updated: Jul 26, 2026
Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
Published on: August 10, 2012
Finding an Optimal Level of GDNF Overexpression: Insights from Dopamine Cycling
1Neuroscience Center, University of Helsinki, 00014, Helsinki, Finland. pepin.marshall@helsinki.fi.
Abstract:
The application of glial cell line-derive neurotrophic factor (GDNF) to cell cultures and animal models has demonstrated positive effects upon dopaminergic neuronal survival and development, function, restoration, and protection. On this basis, recombinant GDNF protein has been trialled in the treatment of late-stage human Parkinson's disease patients with only limited success that is likely due to a lack of viable receptor targets in an advanced state of neurodegeneration. The latest research points to more refined approaches of modulating GDNF signalling and an optimal quantity and spatial regulation of GDNF can be extrapolated using regulation of dopamine as a proxy measure. The basic research literature on dopaminergic effects of GDNF in animal models is reviewed, concluding that a twofold increase in natively expressing cells increases dopamine turnover and maximises neuroprotective and beneficial motor effects whilst minimising hyperdopaminergia and other side-effects. Methodological considerations for measurement of dopamine levels and neuroanatomical distinctions are made between populations of dopamine neurons and their respective effects upon movement and behaviour that will inform future research into this still-relevant growth factor.
Insights
Glial cell line-derived neurotrophic factor (GDNF) shows promise for Parkinson's disease. Optimal GDNF levels, guided by dopamine regulation, maximize benefits while minimizing side effects.
Area of Science:
- Neuroscience
- Neurobiology
- Molecular Biology
Background:
- Glial cell line-derived neurotrophic factor (GDNF) supports dopaminergic neuron survival and function.
- Previous trials of recombinant GDNF in Parkinson's disease patients yielded limited success due to advanced neurodegeneration.
- Current research focuses on refining GDNF signaling modulation.
Purpose of the Study:
- To review animal model research on GDNF's dopaminergic effects.
- To determine optimal GDNF levels for therapeutic benefit.
- To inform future GDNF-based Parkinson's disease research.
Main Methods:
- Review of existing literature on GDNF and dopaminergic systems in animal models.
- Analysis of dopamine regulation as a proxy for GDNF efficacy.
- Consideration of methodological factors in dopamine measurement and neuroanatomy.
Main Results:
- A twofold increase in GDNF-expressing cells maximizes dopamine turnover and motor benefits.
- Higher GDNF levels minimize adverse effects like hyperdopaminergia.
- Dopamine neuron populations exhibit distinct effects on movement and behavior.
Conclusions:
- Optimizing GDNF quantity and spatial regulation is crucial for Parkinson's disease treatment.
- Dopamine regulation serves as a reliable indicator for GDNF efficacy.
- Future research should consider neuroanatomical distinctions for targeted GDNF therapies.
More Related Videos
09:35Environmental Modulations of the Number of Midbrain Dopamine Neurons in Adult Mice
Published on: January 20, 2015
12:13Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies
Published on: July 11, 2019
Related Concept Videos
01:12GPCR Desensitization
01:09GPCRs Regulate Adenylyl Cylase Activity
Two...